Yashar Sarbaz | Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Yashar Sarbaz | Neuroscience | Best Researcher Award

Full-Time Faculty, ECE department at University of Tabriz, Iran

Dr. Yashar Sarbaz is a distinguished Iranian researcher specializing in biomedical engineering, with a focus on neurodegenerative disease modeling. Born on May 20, 1981, in Tabriz, Iran, he has consistently demonstrated academic excellence and a profound commitment to advancing medical science through interdisciplinary approaches. Dr. Sarbaz’s work integrates bioelectric engineering, control systems, and computational neuroscience, aiming to develop innovative solutions for complex neurological disorders. His extensive research has significantly contributed to the understanding and potential treatment of diseases such as Parkinson’s and Huntington’s.

Professional Profile

Education

Dr. Sarbaz’s academic journey commenced at the University of Tabriz, where he earned his Bachelor of Science in Electronic Engineering in 2002, graduating at the top of his class with a GPA of 17.44/20. He then pursued a Master of Science in Control Engineering at Sharif University of Technology, completing his degree in 2004 with a GPA of 18.19/20 and again ranking first in his class. His master’s thesis focused on modeling Parkinson’s disease and its treatment. In 2011, Dr. Sarbaz obtained his Ph.D. in Bioelectric Engineering from Amirkabir University of Technology. His doctoral research, titled “Modeling Parkinson Disease Using Chaotic Theory,” showcased his ability to apply complex mathematical frameworks to biomedical challenges, reflecting his interdisciplinary expertise.

Professional Experience

Dr. Sarbaz’s professional career began as a teaching assistant in the Department of Electrical Engineering at the University of Tabriz from 1998 to 2002. He continued in this role at Sharif University of Technology between 2002 and 2004, concurrently serving as a research assistant. From 2004 to 2006, he was a member of the academic staff at Sahand University of Technology. In 2005, he contributed as the Vice Scientific Committee Chair for the 12th Iranian Conference on Biomedical Engineering. Following his Ph.D., Dr. Sarbaz held teaching positions at Azad Islamic University and later returned to Sahand University. Since 2012, he has been a faculty member in the Department of Emerging Technologies at the University of Tabriz, where he continues to engage in teaching and research.

Research Interests

Dr. Sarbaz’s research interests are diverse and interdisciplinary, encompassing the modeling and simulation of biological systems, particularly neural diseases. He is proficient in system identification, the design of compensators and controllers, and the development of electronic circuits. His expertise extends to chaos theory, evolutionary and genetic algorithms, neural networks, and optimization techniques. Dr. Sarbaz is also deeply involved in electrophysiology and computational neuroscience, focusing on the design of rehabilitation systems. His work aims to bridge the gap between engineering and medicine, utilizing advanced computational methods to address complex biomedical challenges.

Research Skills

Dr. Sarbaz possesses a robust set of research skills that align with his interdisciplinary interests. He is adept at mathematical modeling and simulation of biological systems, employing system identification techniques to understand and predict system behaviors. His proficiency in designing electronic circuits and control systems is complemented by his application of chaos theory to model complex physiological phenomena. Dr. Sarbaz utilizes evolutionary and genetic algorithms for optimization problems and applies neural network methodologies to interpret complex data patterns. His skills in electrophysiology and computational neuroscience are instrumental in developing innovative rehabilitation systems and advancing the understanding of neural disorders.

Awards and Honors

Throughout his academic and professional career, Dr. Sarbaz has been recognized for his contributions to biomedical engineering and neuroscience. He consistently graduated at the top of his class during his academic pursuits, reflecting his dedication and excellence. His role as Vice Scientific Committee Chair at the 12th Iranian Conference on Biomedical Engineering in 2005 highlights his leadership within the scientific community. While specific awards and honors are not detailed in the provided information, Dr. Sarbaz’s extensive publication record and active participation in academic conferences underscore his respected status in his field.

Conclusion

Dr. Yashar Sarbaz exemplifies a commitment to advancing biomedical engineering through interdisciplinary research and education. His academic excellence, professional experience, and diverse research interests have positioned him as a leading figure in the modeling and treatment of neurodegenerative diseases. Dr. Sarbaz’s work not only contributes to the scientific understanding of complex neurological disorders but also holds promise for developing innovative therapeutic strategies. His dedication to integrating engineering principles with medical research continues to inspire and drive progress in the biomedical field.

Publication Top Notes

  1. A robust method for Parkinson’s disease diagnosis: Combining electroencephalography signal features with reconstructed phase space images

    • Author(s): Farnaz F. Garehdaghi, Yashar Y. Sarbaz
    • Year: 2025
  2. Cortical complexity alterations in motor subtypes of Parkinson’s disease: A surface-based morphometry analysis of fractal dimension

    • Author(s): Yousef Y. Dehghan, Yashar Y. Sarbaz
    • Year: 2024
  3. The influence of mental calculations on brain regions and heart rates

    • Author(s): Morteza M. Jafari Malali, Yashar Y. Sarbaz, Sepideh S. Zolfaghari, Armin A. Khodayarlou
    • Year: 2024
    • Citations: 1
  4. EEG-based classification of Alzheimer’s disease and frontotemporal dementia: a comprehensive analysis of discriminative features

    • Author(s): Mehran M. Rostamikia, Yashar Y. Sarbaz, Somayeh S. Makouei
    • Year: 2024
    • Citations: 2
  5. Extracting brain behavior change in patients with migraine by quantitative analysis of electroencephalogram signal of patients compared to healthy people

    • Author(s): Yashar Y. Sarbaz, Farnaz F. Garehdaghi, Saeed S. Meshgini
    • Year: 2024

 

Jiangang Duan | Neuroscience | Best Researcher Award

Prof. Jiangang Duan | Neuroscience | Best Researcher Award

Chief Physician at Xuanwu Hospital, Capital Medical University, China

Dr. Jiangang Duan is a distinguished neurologist and researcher at the Department of Emergency and Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. With over two decades of clinical and academic experience, he specializes in cerebral venous thrombosis (CVT), ischemic stroke, and neuroprotective therapies. His groundbreaking work includes the development of diagnostic imaging techniques, exploration of biomarkers for venous infarcts, and innovative non-drug therapies for ischemic stroke. Dr. Duan is also a dedicated mentor and educator, shaping the next generation of neurologists through his teaching and supervision of postgraduate students. His extensive research has been published in prestigious journals, and he has contributed to the creation of national guidelines for the management of cerebrovascular diseases.

Professional Profile

Education

Dr. Duan holds a Ph.D. and M.D. in Neurology from West China Hospital, Sichuan University (2004–2007), where his dissertation focused on the neuroprotective effects of acupuncture in ischemic stroke models. He earned an M.S. in Human Anatomy and Histoembryology from West China College of Basic and Forensic Medicine (2001–2004), researching ganglioside GM1’s role in neural stem cell differentiation. His academic journey began with a B.S. in Clinical Medicine from Inner Mongolia Medical College (1991–1996), establishing a strong foundation for his future contributions to neuroscience.

Professional Experience

Dr. Duan is an Associate Professor at the Department of Emergency and Neurology, Capital Medical University, Beijing, since 2015. His clinical and research roles involve pioneering treatment strategies for CVT and ischemic strokes. He previously served as a visiting scholar at the Chinese University of Hong Kong (2012–2013), contributing to long-term studies on cardiovascular risks in diabetic patients. Dr. Duan’s work at Xuanwu Hospital includes innovative projects like using DOACs for CVT treatment, evaluating glucocorticoid efficacy, and exploring NF-κB-NLRP3 inflammasome signaling in thrombosis pathogenesis. His efforts have significantly influenced the field of cerebrovascular disease management in China and beyond.

Research Interests

Dr. Duan’s research primarily focuses on the mechanisms and treatments of cerebrovascular disorders, particularly CVT and ischemic strokes. His interests extend to the role of inflammation in thrombosis, novel non-drug therapies for neuroprotection, and the efficacy of anticoagulants like Dabigatran in CVT management. He also investigates biomarkers, such as serum Claudin-5, for predicting venous infarcts and utilizes advanced imaging techniques like MRBTI to evaluate thrombosis stages. His translational research bridges clinical and preclinical studies, aiming to improve diagnostics, treatments, and outcomes for patients with cerebrovascular diseases.

Research Skills

Dr. Duan is proficient in advanced diagnostic imaging methods, including MRBTI, and skilled in conducting both retrospective and prospective studies. He excels in randomized controlled trials, having evaluated the safety and efficacy of anticoagulants and glucocorticoids in cerebrovascular diseases. His expertise in biomarker identification and inflammasome signaling pathways demonstrates his command of molecular and clinical neurology. Additionally, Dr. Duan is adept at statistical analysis, multidisciplinary collaboration, and guideline development, making him a leading figure in cerebrovascular research and clinical practice.

Honors and Awards

Dr. Duan has received numerous accolades, including the prestigious Chinese Medical Science and Technology Award (2019) for his work on non-drug therapies for ischemic stroke. In 2018, he was awarded a fellowship by the European Stroke Research Foundation, where he presented groundbreaking research at the 27th European Stroke Conference in Athens, Greece. He was also recognized with the Outstanding Mentor Management Award in 2021 for his exemplary guidance of postgraduate students. Earlier honors include a scholarship for master’s students at Sichuan University (2002–2003) and recognition for his contributions to cerebrovascular disease management guidelines in China.

Conclusion

Dr. Jiangang Duan is a strong contender for the Best Researcher Award. His robust track record in neurology research, impactful mentorship, and contributions to clinical practice guidelines highlight his expertise and dedication. While there is room to amplify his global impact through high-impact publications and leadership in international projects, his achievements already position him as a distinguished researcher in his field.

Publication Top Notes

  1. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
    Authors: Ma, H., Gu, Y., Bian, T., Ji, X., Duan, J.
    Journal: International Journal of Stroke
    Year: 2024
    Volume & Pages: 19(6), pp. 635–644
    Citations: 2
  2. Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): Rationale and design
    Authors: Bian, H., Wang, X., Liu, L., Wang, L., Ji, X.
    Journal: Brain and Behavior
    Year: 2024
    Volume & Pages: 14(4), e3353
  3. Night shift work was associated with functional outcomes in acute ischemic stroke patients treated with endovascular thrombectomy
    Authors: Yu, W., Ma, J., Guo, W., Zhao, W., Ji, X.
    Journal: Heliyon
    Year: 2024
    Volume & Pages: 10(4), e25916
  4. Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio
    Authors: Yu, W., Jia, M., Guo, W., Song, H., Ji, X.
    Journal: Current Neurovascular Research
    Year: 2024
    Volume & Pages: 21(1), pp. 6–14
  5. Severe deep cerebral venous thrombosis associated with ulcerative colitis: one case report | 重 症 脑 深 静 脉 血 栓 形 成 并 溃 疡 性 结 肠 炎 一 例
    Authors: Wang, J.-B., Gu, Y.-Q., Duan, J.-G.
    Journal: Chinese Journal of Contemporary Neurology and Neurosurgery
    Year: 2024
    Volume & Pages: 24(3), pp. 193–198
  6. Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis
    Authors: Guo, W., Li, N., Xu, J., Zhao, W., Ji, X.
    Journal: Journal of Clinical Pharmacy and Therapeutics
    Year: 2024
    Volume & Pages: Article ID: 1171260
  7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
    Authors: Scutelnic, A., van de Munckhof, A., Krzywicka, K., Levi, M., van Gorp, E.C.M.
    Journal: European Stroke Journal
    Year: 2023
    Volume & Pages: 8(4), pp. 1001–1010
    Citations: 1
  8. Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis
    Authors: Liu, L., Zhou, C., Jiang, H., Zhou, C., Ji, X.
    Journal: Thrombosis Journal
    Year: 2023
    Volume & Pages: 21(1), Article 78
    Citations: 1
  9. Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
    Authors: Chen, S., Chen, H., Duan, J., Liu, R., Xing, Y.
    Journal: Ultrasound in Medicine and Biology
    Year: 2023
    Volume & Pages: 49(10), pp. 2221–2226
  10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
    Authors: van de Munckhof, A., Borhani-Haghighi, A., Aaron, S., Ferro, J.M., Coutinho, J.M.
    Journal: International Journal of Stroke
    Year: 2023
    Volume & Pages: 18(9), pp. 1112–1120
    Citations: 3